Lv11
30 积分 2024-07-02 加入
Compstatins: the dawn of clinical C3-targeted complement inhibition
59分钟前
已完结
C3 Glomerulopathy: Pathogenesis and Treatment
1小时前
已完结
Complement in human disease: approved and up-and-coming therapeutics
3天前
已完结
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot?
26天前
已完结
Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges
1个月前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
1个月前
已完结
GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced Parkinsonism
1个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
1个月前
已完结
Global epidemiology of rheumatoid arthritis
2个月前
已完结
Oncogenic KrasG12Dspecific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8+T cells dependent manner
2个月前
已完结
皖公网安备34019202002308
